AlphaStocks
2.8
Avoid

Artivion, Inc. (AORT)

As of Sep 19, 2026, Artivion, Inc. (AORT) scores 2.8/10 on AlphaStocks' five-model composite, #158 of 168 Health Care stocks. At $23, AORT trades 111% above its model fair value of $11.

Health Care / Health Care Equipment

S&P SmallCap 600

$23.34

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#158out of 168 in Health Care

Is ARTIVION, INC. a Good Investment in 2026?

ARTIVION, INC. (AORT) scores 2.8 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates ARTIVION, INC. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.6% · ROC 10%. ARTIVION, INC. currently trades 111% above its estimated fair value of $11. ARTIVION, INC. ranks #158 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E112.7ROE1.9Market Cap1B

Estimated Fair Value

$11.05111% above

Trading above estimated fair value. P/e of 113x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield 2.6% · ROC 10%

Frequently Asked Questions

Is ARTIVION, INC. (AORT) a good investment?
As of Sep 19, 2026, Artivion, Inc. (AORT) scores 2.8/10 on AlphaStocks' five-model composite, #158 of 168 Health Care stocks. At $23, AORT trades 111% above its model fair value of $11. That score is below average, suggesting caution.
What is ARTIVION, INC.'s Piotroski F-Score?
ARTIVION, INC.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AORT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $11, AORT appears overvalued. The stock currently trades 111% above its estimated fair value. Trading above estimated fair value. P/e of 113x implies high growth expectations.
How does AORT compare to other Health Care stocks?
ARTIVION, INC. ranks #158 out of 168 stocks in the Health Care sector, placing it in the top 94% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about AORT?
AlphaStocks evaluates AORT using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 2.8/10.

Similar Stocks

INSPUFPTBDX

Compare AORT with

AORT vs INSPAORT vs UFPTAORT vs BDX

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer